Bimekizumab for treating active psoriatic arthritis

Equality Impact Assessment (Guidance development) (PDF 147 KB)

Supporting documentation Register of interests (PDF 126 KB)

Final draft guidance

Final draft guidance (PDF 164 KB)

Committee papers (PDF 4.93 MB)

Final scope (PDF 198 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 256 KB)

Final stakeholder list (PDF 163 KB)

Equality impact assessment (Scoping) (PDF 128 KB)

Draft matrix post referral (PDF 162 KB)

Draft scope post referral (PDF 200 KB)